Each day at ASM Microbe 2019 offers you the chance to delve into your scientific interest and specialties, discover cutting-edge research in the poster and oral presentations, and connect with a world of microbiology experts. View the ASM Microbe 2019 Schedule at a Glance for a preliminary peek at what is in store for you.

Presentations developed in cooperation with GARDP, CARB-X, and REPAIR Impact Fund. Antimicrobial resistance (AMR) continues to be a major problem that is not being addressed adequately by the pharmaceutical industry. Academic research is more frequently serving as a source for novel antimicrobial agents to treat infections caused by antibiotic-resistant organisms. In this session, drug discovery […]

Speakers include Kevin Outterson, Executive Director of CARB-X. The Royal Swedish Academy of Engineering Sciences (IVA) is hosting the yearly conference for the International Council of Academies of Engineering and […]

In this webinar, Dr Manica Balasegaram, GARDP’s Executive Director will highlight GARDP’s role in accelerating the implementation of WHO’s Global Action Plan, and share GARDP’s updated strategy. Following his presentation, […]

Additional Details Forthcoming.

The overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks of development for various kinds of antibacterial products. In this […]

Please share any pipeline additions and changes that you are aware of by 22 July 2019. Download and use this form to provide updates. The latest pipeline update (as of July 1, 2018), can be found as a manuscript (Theuretzbacher et al. Lancet ID 2018), and as a set of summary tables. Contact Sarah Paulin (paulins@who.int).

This is an open session hosted by the National Academy of Sciences, Engineering, and Medicine.  The 1.5-day public workshop to will be held on July 24-25, 2019 in Washington, D.C and focus on the translation of federal investments in biomedical science to innovation in drug development and how the public benefits from that investment in […]

Keynote lecture given by Kevin Outterson, Executive Director of CARB-X. Additional details forthcoming.

The overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks of development for various kinds of antibacterial products. In this webinar, Lena Friberg and Elisabet Nielsen (Department of Pharmaceutical Biosciences, Uppsala University, Sweden), will discuss: Population PK modelling to characterize drug exposure and variability PKPD-modelling […]